Cargando…
The ALFA project: A research platform to identify early pathophysiological features of Alzheimer's disease
INTRODUCTION: The preclinical phase of Alzheimer's disease (AD) is optimal for identifying early pathophysiological events and developing prevention programs, which are shared aims of the ALFA project, including the ALFA registry and parent cohort and the nested ALFA+ cohort study. METHODS: The...
Autores principales: | Molinuevo, José Luis, Gramunt, Nina, Gispert, Juan Domingo, Fauria, Karine, Esteller, Manel, Minguillon, Carolina, Sánchez-Benavides, Gonzalo, Huesa, Gema, Morán, Sebastián, Dal-Ré, Rafael, Camí, Jordi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644283/ https://www.ncbi.nlm.nih.gov/pubmed/29067295 http://dx.doi.org/10.1016/j.trci.2016.02.003 |
Ejemplares similares
-
APOE-ε4 risk variant for Alzheimer's disease modifies the association between cognitive performance and cerebral morphology in healthy middle-aged individuals
por: Cacciaglia, Raffaele, et al.
Publicado: (2019) -
Incidental findings on brain MRI of cognitively normal first-degree descendants of patients with Alzheimer's disease: a cross-sectional analysis from the ALFA (Alzheimer and Families) project
por: Brugulat-Serrat, Anna, et al.
Publicado: (2017) -
Modeling practice effects in healthy middle-aged participants of the Alzheimer and Families parent cohort
por: Sánchez-Benavides, Gonzalo, et al.
Publicado: (2016) -
Cerebral amyloid‐β load is associated with neurodegeneration and gliosis: Mediation by p‐tau and interactions with risk factors early in the Alzheimer's continuum
por: Salvadó, Gemma, et al.
Publicado: (2021) -
Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's continuum
por: Milà‐Alomà, Marta, et al.
Publicado: (2020)